GENERALI, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 243
EU - Europa 202
AS - Asia 59
Continente sconosciuto - Info sul continente non disponibili 1
Totale 505
Nazione #
US - Stati Uniti d'America 228
IE - Irlanda 73
UA - Ucraina 36
CN - Cina 32
IT - Italia 30
GB - Regno Unito 16
CA - Canada 15
DE - Germania 13
FI - Finlandia 10
SE - Svezia 10
VN - Vietnam 10
BG - Bulgaria 6
HK - Hong Kong 6
TR - Turchia 6
IN - India 4
BE - Belgio 3
FR - Francia 3
AL - Albania 1
CH - Svizzera 1
EU - Europa 1
PK - Pakistan 1
Totale 505
Città #
Dublin 73
Chandler 52
Jacksonville 31
Ann Arbor 21
Toronto 15
Dearborn 14
Milan 11
Beijing 9
Boston 7
Dong Ket 7
Lawrence 7
Modena 7
Mountain View 7
Hong Kong 6
Izmir 6
Southend 6
Wilmington 6
Boardman 5
Helsinki 5
Hefei 4
Houston 4
New York 4
Redmond 4
Brussels 3
Mumbai 3
Woodbridge 3
Ashburn 2
Paris 2
Sabbioneta 2
Seattle 2
Bovisio-Masciago 1
Changsha 1
Chengdu 1
Chongqing 1
Clearwater 1
Dongguan 1
Guangzhou 1
Islamabad 1
Jinan 1
Kunming 1
Nanchang 1
Nanjing 1
Norwalk 1
Pune 1
Redwood City 1
San Giovanni Rotondo 1
Shaoxing 1
Taiyuan 1
Tappahannock 1
Tirana 1
Totale 348
Nome #
A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer 114
Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the "biological window therapy" 75
Role of targeted agents in neuroendocrine tumours: results from a meta-analysis 74
Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors: a meta-regression of randomised prospective studies 69
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer 68
New omics information for clinical trial utility in the primary setting 64
Endocrine‐based treatments in clinically‐relevant subgroups of hormone receptor‐positive/HER2‐negative metastatic breast cancer: systematic review and meta‐analysis 58
COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment 6
Phosphorylated ER alpha, HIF-1 alpha, and MAPK Signaling As Predictors of Primary Endocrine Treatment Response and Resistance in Patients With Breast Cancer 5
Totale 533
Categoria #
all - tutte 2.327
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.327


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 0 2 7
2019/202083 7 2 9 1 7 12 20 6 7 4 0 8
2020/202165 1 6 0 7 6 2 7 0 14 1 9 12
2021/202251 3 14 0 1 3 2 2 10 6 2 1 7
2022/2023195 10 4 7 17 16 14 1 15 94 1 9 7
2023/202454 8 3 4 0 5 13 8 12 1 0 0 0
Totale 533